Rebamipide (International)

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0111911-87-6

Chemical Formula

C19-H15-Cl-N2-O4

Molecular Weight

371

Therapeutic Category

Treatment of peptic ulcer

Chemical Name

(±)-α-(p-Chlorobenzamido)-1,2-dihydro-2-oxo-4-quinolinepropionic acid

Foreign Names

• Rebamipidum (Latin)
• Rebamipid (German)
• Rebamipide (French)
• Rebamipida (Spanish)

Generic Names

• Rebamipide (OS: JAN)
• OPC 12759 (IS)
• Pramipide (IS)
• Proamipide (IS)
• Rebamipide (PH: JP XVII)

Brand Names

• Bamedin
  Samjin, South Korea
• Bapid
  Unison, Thailand
• Becantex
  Pharos, Indonesia
• Gastrix
  Chunggei, Philippines
• Huining
  Yuanlijian Pharm, China
• Medica Rebacid
  Medica Korea, South Korea
• Mucogen
  Macleods, Georgia
• Mucopan
  Sungwon, South Korea
• Mucopro
  Kyung Dong Pharm, Philippines
• Mucoprotec
  Kyung Dong Pharm, Philippines
• Mucosta
  Korea Otsuka Pharmaceutical, South Korea; Otsuka, China; Otsuka, Egypt; Otsuka, Indonesia; Otsuka, Malaysia; Otsuka, Philippines; Otsuka, Thailand; Otsuka Pharmaceutical, Japan; Otsuka Pharmaceutical, Vietnam
• Mucosta 20%
  Otsuka Pharmaceutical, Japan
• Mucosta UD 2%
  Otsuka Pharmaceutical, Japan
• Rebamax
  Simex, Indonesia
• Rebamid
  Lapi Laboratories, Indonesia
• Rebamipide 20% Amel
  Kyowa Yakuhin, Japan
• Rebamipide 20% ASKA
  ASKA Seiyaku Asuka, Japan
• Rebamipide 20% Nichi-Iko
  Nichi-Iko Pharmaceutical, Japan
• Rebamipide 20% Takata
  Takata Pharmaceutical, Japan
• Rebamipide 20% TCK
  Tatsumi Kagaku, Japan
• Rebamipide 20% TYK
  Taisho Yakuhin, Japan
• Rebamipide Amel
  Kyowa Yakuhin, Japan
• Rebamipide ASKA
  ASKA Seiyaku Asuka, Japan
• Rebamipide Chemiphar
  Nippon Chemiphar, Japan
• Rebamipide DK
  Daiko Seiyaku, Japan
• Rebamipide EMEC
  Ohara Yakuhin, Japan
• Rebamipide JG
  Nihon Generic, Japan
• Rebamipide KTB
  Kotobuki Seiyaku, Japan
• Rebamipide Kukje
  Kukje, South Korea
• Rebamipide Kyorin
  Kyorin Rimedio, Japan
• Rebamipide Lapi
  Lapi Laboratories, Indonesia
• Rebamipide MED
  Medisa Shinyaku, Japan
• Rebamipide Meiji
  Meiji Seika Pharma, Japan
• Rebamipide Mylan
  Mylan Seiyaku, Japan
• Rebamipide Nichi-iko
  Nichi-Iko Pharmaceutical, Japan
• Rebamipide NP
  Nipro, Japan
• Rebamipide NPI
  Nihon Yakuhin Kogyo, Japan
• Rebamipide NS
  Nisshin Pharmaceutical, Japan
• Rebamipide OD Meiji
  Meiji Seika Pharma, Japan
• Rebamipide OD NS
  Nisshin Pharmaceutical, Japan
• Rebamipide OD YD
  Yoshindo, Japan
• Rebamipide Pfizer
  Pfizer Japan, Japan
• Rebamipide Sawai
  Sawai Seiyaku, Japan
• Rebamipide SN
  Shiono Kemikaru, Japan
• Rebamipide Takata
  Takata Pharmaceutical, Japan
• Rebamipide Tanabe
  Tanabe Mitsubishi Pharma, Japan
• Rebamipide TCK
  Tatsumi Kagaku, Japan
• Rebamipide Towa
  Towa Yakuhin, Japan
• Rebamipide TSU
  Tsuruhara Seiyaku Pharmaceutical, Japan
• Rebamipide TYK
  Taisho Yakuhin, Japan
• Rebamipide Yarindo
  Yarindo Farmatama, Indonesia
• Rebamipide YD
  Yoshindo, Japan
• Rebamipide ZE
  Zensei Yakuhin, Japan
• Rebis
  Daewoo, South Korea
• Recomide
  Yuhan, South Korea
• Remapride
  Kyung Dong Pharm, Philippines
• Remide
  Hanmi, South Korea
• Repampia
  Daewoong Pharmaceuticals, Vietnam
• Restam
  Hana Pharm, South Korea
• Sysmuco
  Fahrenheit, Indonesia
• Ulbamed
  Futamed, Indonesia

Glossary

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer